1Lagakos SW,Gable AR. Challenges to HIV prevention-seeking effective measures in the absence of a vaccine[J]. N Engl J Med,358,358(15) :1543-1545.
2Watson-Jones D,Weiss HA,Rusizoka M,et al. Effect of herpes simplex suppression on incidence of HIV among women in tanzania[J]. N Engl J Med,2008,358(15) :1560-1571.
3Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update[J]. Hepatology International,2008,2(3),263-283.
4Mitniek CD, Shin SS, Seung K J, et al. Comprehensive treatment of extensively drug-resistant tuberculosis[J]. N Engl J Med, 2008,359(6) : 563-574.
5yon Gottberg A, Klugman KP, Cohen C, et al. Emergence of levofloxacin- non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study [J]. Lancet, 2008,371 (9618), 1108-1113.
6Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America[J]. CID, 2008,46 (3) : 327-360.
7DeUinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008,36 (1) 296-327.
8Sprung CL, Annane D, Keh D, et al. Hydroeortisone therapy for patients with septic shock[J]. N Engl J Med, 2008,358(9) 111-124.
9Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusionin patients with septic shoek[J]. N Engl J Med,2008,358(9) :877-887.
10French GL,What's new and not so new on the antimicrobial horizon? [J]. Clin Microbiol Infect, 2008,14(Suppl 6) : 19-29.
3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
